Track topics on Twitter Track topics that are important to you
TechnoVax, Inc., a biotechnology developer of novel vaccines has received a two-year $1,481,000 SBIR-II grant from the National Institute of Allergy and Infectious Diseases (NIAID...
Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...
TechnoVax is a privately held biotechnology company based in Westchester County (New York) and specializes in vaccine development using its unique and innovative VLP platform tech...
TechnoVax is a privately held biotechnology company based in Tarrytown (N.Y.) specializing in vaccine development using unique and innovative platform technologies. The company is...
We have published hundreds of TechnoVax, Inc. news stories on BioPortfolio along with dozens of TechnoVax, Inc. Clinical Trials and PubMed Articles about TechnoVax, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TechnoVax, Inc. Companies in our database. You can also find out about relevant TechnoVax, Inc. Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...